dienogest: Clinical Trials

7 trials of dienogest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Completed 6, Not yet recruiting 1

Follow dienogest: new trials by email Literature Review of dienogest trials Research Report on dienogest

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ttt of Adenomyosis
Dienogest 2 mg orally, UAE - Adenomyosis
Phase 1Not yet recruitingAl-Azhar University1002025-01-012024-12-06
Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet - Bioequivalence
Phase 1CompletedLaboratorios Andromaco S.A.102022-03-122022-04-18
Bioavailability of Dienogest 2.0 mg With Regards to Reference Product
Dienogest 2.0 mg Test Drug, Dienogest 2.0 mg Reference Product - Bioequivalence
Phase 1CompletedLaboratorios Andromaco S.A.302019-12-072020-01-18
Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product - Bioequivalence
Phase 1CompletedLaboratorios Andromaco S.A.102019-11-092019-12-10
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability
Phase 1CompletedBayer682017-11-292020-04-15
Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium, BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG), BAY 86-7660,levomefolate calcium - Pharmacology, Clinical
Phase 1CompletedBayer432009-09-012016-08-01
Pharmacodynamic Characterization of Dienogest
Dienogest (81150037), Dienogest (81150231), Dienogest (SH T00660A) - Pharmacodynamics
Phase 1CompletedBayer1022008-09-012015-01-27

Conditions studied

Adenomyosis (1)

Sponsors

Bayer (3)  ·  Laboratorios Andromaco S.A. (3)  ·  Al-Azhar University (1)

Countries

Chile (2)  ·  Germany (2)  ·  Egypt (1)  ·  India (1)  ·  Netherlands (1)

Top investigators

R. Amirtha, MD (1)

Results publications

PMID 22128200

NIH funding

2008 (1), 2009 (1), 2017 (1)